Apollo Endosurgery, Inc. (APEN), relating to its proposed sale to Boston Scientific Corp. Under the terms of the merger, APEN shareholders will receive $10.00 in cash per share they own.
Apollo Endosurgery, Inc. (APEN), relating to its proposed sale to Boston Scientific Corp. Under the terms of the merger, APEN shareholders will receive $10.00 in cash per share they own.